BHVN - CIK 0001935979
The table below shows Biohaven Ltd.'s balance sheet line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash & equivalents | $229.96M | $99.13M | $248.40M | $204.88M |
| Short-term investments | $89.18M | $386.86M | $133.42M | $260.46M |
| Receivables | - | - | - | - |
| Inventory | - | - | - | - |
| Total current assets | $368.33M | $538.47M | $442.45M | $586.97M |
| Property, plant & equipment | $15.96M | $17.32M | $17.19M | $17.51M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Goodwill | $1.39M | $1.39M | $1.39M | $1.39M |
| Total assets | $451.45M | $615.11M | $513.21M | $661.78M |
| Accounts payable | $11.64M | $18.03M | $15.58M | $10.70M |
| Total current liabilities | $115.93M | $154.23M | $55.42M | $90.02M |
| Long-term debt | - | - | - | - |
| Total liabilities | $399.38M | $191.67M | $85.24M | $123.01M |
| Retained earnings | -$2.08B | -$1.35B | -$499.29M | -$91.12M |
| Total equity | $52.07M | $423.44M | $427.98M | $538.77M |